This afternoon we watched Zimmer Biomet rise 2.1% to a price of $109.81 per share. The Large-Cap Specialty Industrial Machinery company is now trading -9.88% below its average target price of $121.85. Analysts have set target prices ranging from $105.0 to $150.0 per share for Zimmer Biomet, and have given the stock an average rating of hold.
Zimmer Biomet's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4.0%. The stock's short ratio is 3.59. The company's insiders own 0.2% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 93.6%. In conclusion, we believe there is mixed market sentiment regarding Zimmer Biomet.
Institutions Invested in Zimmer Biomet
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-12-31 | Vanguard Group Inc | 12% | 22,886,162 | $2,513,129,393 |
| 2024-12-31 | Dodge & Cox Inc | 10% | 19,118,436 | $2,099,395,410 |
| 2024-12-31 | Blackrock Inc. | 8% | 16,131,834 | $1,771,436,652 |
| 2024-12-31 | Price (T.Rowe) Associates Inc | 7% | 14,760,444 | $1,620,844,319 |
| 2024-12-31 | State Street Corporation | 5% | 8,984,077 | $986,541,473 |
| 2024-12-31 | American Century Companies Inc | 3% | 5,921,397 | $650,228,590 |
| 2024-12-31 | Geode Capital Management, LLC | 2% | 4,877,062 | $535,550,166 |
| 2024-12-31 | Primecap Management Company | 2% | 4,797,150 | $526,775,029 |
| 2024-12-31 | Invesco Ltd. | 2% | 4,263,734 | $468,200,620 |
| 2024-12-31 | Van Eck Associates Corporation | 2% | 3,955,449 | $434,347,845 |
